Evidence map›Paper›PMID 30241212›Full record

ArticleJournal of global oncology2018

Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic Melanoma.

Erika Ruiz-Garcia, Juan A Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Cesar Lopez-Camarillo, Laurence A Marchat, Saul Lino-Silva and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Erika Ruiz-GarciaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Juan A Matus-SantosErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Jorge Alberto Guadarrama-OrozcoErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Miguel Angel Alvarez-AvitiaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Jose Luis Aguilar-PonceErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Edith Fernandez-FigueroaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Jessica Maldonado-MendozaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Cesar Lopez-CamarilloErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Laurence A MarchatErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Saul Lino-SilvaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Mario Cuellar-HubbeErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Jamie de la Garza-SalazarErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Abelardo Meneses-GarcíaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Horacio Astudillo-de la VegaErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Hector Martinez-SaidErika Ruiz-Garcia, Juan A. Matus-Santos, Jorge Alberto Guadarrama-Orozco, Miguel Angel Alvarez-Avitia, Jose Luis Aguilar-Ponce, Edith Fernandez-Figueroa, Jessica Maldonado-Mendoza, Saul Lino-Silva, Mario Cuellar-Hubbe, Jamie de la Garza-Salazar, Abelardo Meneses-García, and Hector Martinez-Said, National Cancer Institute; Cesar Lopez-Camarillo, Autonomous University of Mexico City; Laurence A. Marchat, National Polytechnic Institute; and Horacio Astudillo-de la Vega, Medical Center Siglo XXI, Mexico City, Mexico.
Ação Educativa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe BRAF V600E mutation has been described in melanomas occurring in the Caucasian, European, and Asian populations. However, in the Mexican population, the status and clinical significance of BRAF mutation has not been researched on a large scale.

methodsConsecutive BRAF-tested Mexican patients with metastatic melanoma (n = 127) were analyzed for mutations in exon 15 of the BRAF gene in genomic DNA by real-time polymerase chain reaction technology for amplification and detection. The results were correlated with the clinical-pathologic features and the prognosis of the patients.

resultsThe frequency of somatic mutation V600E within the BRAF gene was 54.6% (43 of 127 patients). Nodular melanoma was the most prevalent subtype in our population, with BRAF mutations in 37.2% (16 of 55 patients). In contrast, superficial spread had a frequency of 18.6% BRAF mutation (eight of 24). Other clinicopathologic features were assessed to correlate with the mutation status.

conclusionThis study searched for the most prevalent BRAF V600E mutation type in melanoma in a heterogeneous population from Mexico. Nodular melanoma was found to be the most prevalent in metastatic presentation and the presence of BRAF V600E mutation, perhaps related to the mixed ancestry; in the north, ancestry is predominantly European and in the south, it is predominantly Asian. The outcomes of the mutation correlations were similar to those found in other populations.

Indexed as

HumansMelanomaMexicoMiddle AgedMutationProto-Oncogene Proteins B-rafProto-Oncogene Proteins B-raf

Identifiers

PMID30241212
PMCPMC6180834
OpenAlexW2626983085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.